TreeWAS – Variant ID: rs6889665

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R39.8 Other and unspecified symptoms and signs involving the urinary system	0.000	0.973	0.027
N32.8 Other specified disorders of bladder	0.000	0.980	0.020
N32.0 Bladder-neck obstruction	0.000	0.983	0.017
N32 Other disorders of bladder	0.000	0.983	0.017
N32.4 Rupture of bladder, nontraumatic	0.000	0.988	0.012
N32.2 Vesical fistula, not elsewhere classified	0.000	0.988	0.012
N32.1 Vesicointestinal fistula	0.000	0.988	0.012
N32.9 Bladder disorder, unspecified	0.000	0.989	0.010
N32.3 Diverticulum of bladder	0.000	0.990	0.010
R39 Other symptoms and signs involving the urinary system	0.000	0.991	0.009
Z03.4 Observation for suspected myocardial infarction	0.000	0.992	0.008
H04.5 Stenosis and insufficiency of lachrymal passages	0.007	0.993	0.000
H04 Disorders of lachrymal system	0.007	0.993	0.000
H04.2 Epiphora	0.007	0.993	0.000
R39.2 Extrarenal uraemia	0.000	0.993	0.007
R39.0 Extravasation of urine	0.000	0.993	0.007
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.000	0.994	0.006
M54.59 Low back pain (Site unspecified)	0.000	0.994	0.006
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.000	0.994	0.006
N30-N39 Other diseases of urinary system	0.000	0.994	0.006
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.005	0.995	0.000
R39.1 Other difficulties with micturition	0.000	0.995	0.005
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.005	0.995	0.000
S61.0 Open wound of finger(s) without damage to nail	0.005	0.995	0.000
H00.0 Hordeolum and other deep inflammation of eyelid	0.005	0.995	0.000
H04.9 Disorder of lachrymal system, unspecified	0.005	0.995	0.000
H04.8 Other disorders of lachrymal system	0.005	0.995	0.000
H04.6 Other changes in lachrymal passages	0.005	0.995	0.000
H04.4 Chronic inflammation of lachrymal passages	0.005	0.995	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.005	0.995	0.000
H04.0 Dacryoadenitis	0.005	0.995	0.000
H00 Hordeolum and chalazion	0.005	0.995	0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.000	0.995	0.005
N36 Other disorders of urethra	0.000	0.995	0.005
H04.1 Other disorders of lachrymal gland	0.005	0.995	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.995	0.005
N36.8 Other specified disorders of urethra	0.000	0.995	0.005
M54.5 Low back pain	0.000	0.995	0.005
H05 Disorders of orbit	0.004	0.995	0.000
O68 Labour and delivery complicated by foetal stress [distress]	0.000	0.996	0.004
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.000	0.996	0.004
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.000	0.996	0.004
N37 Urethral disorders in diseases classified elsewhere	0.000	0.996	0.004
N34 Urethritis and urethral syndrome	0.000	0.996	0.004
N33 Bladder disorders in diseases classified elsewhere	0.000	0.996	0.004
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.004	0.996	0.000
C18.7 Sigmoid colon	0.000	0.996	0.004
M54.57 Low back pain (Lumbosacral region)	0.000	0.996	0.004
H01 Other inflammation of eyelid	0.004	0.996	0.000
H00.1 Chalazion	0.004	0.996	0.000
O26.8 Other specified pregnancy-related conditions	0.004	0.996	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.000	0.996	0.004
H03 Disorders of eyelid in diseases classified elsewhere	0.004	0.996	0.000
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.996	0.004
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
M54 Dorsalgia	0.000	0.996	0.004
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.000	0.996	0.004
M54.99 Dorsalgia, unspecified (Site unspecified)	0.000	0.996	0.004
H05.2 Exophthalmic conditions	0.004	0.996	0.000
N36.9 Urethral disorder, unspecified	0.000	0.996	0.004
N36.3 Prolapsed urethral mucosa	0.000	0.996	0.004
N36.1 Urethral diverticulum	0.000	0.996	0.004
N36.0 Urethral fistula	0.000	0.996	0.004
M54.3 Sciatica	0.000	0.996	0.004
N36.2 Urethral caruncle	0.000	0.996	0.004
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
H02.9 Disorder of eyelid, unspecified	0.004	0.996	0.000
M54.9 Dorsalgia, unspecified	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
C18 Malignant neoplasm of colon	0.000	0.996	0.004
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
M54.36 Sciatica (Lumbar region)	0.000	0.996	0.004
H06.2 Dysthyroid exophthalmos	0.003	0.996	0.000
M54.55 Low back pain (Thoracolumbar region)	0.000	0.996	0.003
M54.54 Low back pain-Thoracic	0.000	0.996	0.003
M54.53 Low back pain-Cervicothoracic	0.000	0.996	0.003
M54.52 Low back pain-Cervical	0.000	0.996	0.003
M54.51 Low back pain-Occipit-atl-axl	0.000	0.996	0.003
M54.50 Low back pain (Multiple sites in spine)	0.000	0.996	0.003
H02 Other disorders of eyelid	0.004	0.996	0.000
E83.1 Disorders of iron metabolism	0.004	0.996	0.000
C18.2 Ascending colon	0.000	0.996	0.004
M54.39 Sciatica (Site unspecified)	0.000	0.996	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.996	0.000
H05.9 Disorder of orbit, unspecified	0.003	0.996	0.000
H05.8 Other disorders of orbit	0.003	0.996	0.000
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.003	0.996	0.000
H05.4 Enophthalmos	0.003	0.996	0.000
H05.3 Deformity of orbit	0.003	0.996	0.000
H05.1 Chronic inflammatory disorders of orbit	0.003	0.996	0.000
H05.0 Acute inflammation of orbit	0.003	0.996	0.000
T40.2 Other opioids	0.003	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
N33.8 Bladder disorders in other diseases classified elsewhere	0.000	0.997	0.003
N33.0 Tuberculous cystitis	0.000	0.997	0.003
N34.3 Urethral syndrome, unspecified	0.000	0.997	0.003
N34.2 Other urethritis	0.000	0.997	0.003
N34.1 Nonspecific urethritis	0.000	0.997	0.003
N34.0 Urethral abscess	0.000	0.997	0.003
N37.8 Other urethral disorders in diseases classified elsewhere	0.000	0.997	0.003
N37.0 Urethritis in diseases classified elsewhere	0.000	0.997	0.003
T18.1 Foreign body in oesophagus	0.003	0.997	0.000
C18.9 Colon, unspecified	0.000	0.997	0.003
H06.3 Other disorders of orbit in diseases classified elsewhere	0.003	0.997	0.000
H06.1 Parasitic infestation of orbit in diseases classified elsewhere	0.003	0.997	0.000
H06.0 Disorders of lachrymal system in diseases classified elsewhere	0.003	0.997	0.000
N35 Urethral stricture	0.000	0.997	0.003
M54.2 Cervicalgia	0.000	0.997	0.003
Z03 Medical observation and evaluation for suspected diseases and conditions	0.000	0.997	0.003
T40.4 Other synthetic narcotics	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
O26 Maternal care for other conditions predominantly related to pregnancy	0.003	0.997	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.000	0.997	0.003
Y43.3 Other antineoplastic drugs	0.003	0.997	0.000
C18.4 Transverse colon	0.000	0.997	0.003
H01.0 Blepharitis	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
H01.9 Inflammation of eyelid, unspecified	0.003	0.997	0.000
H01.8 Other specified inflammation of eyelid	0.003	0.997	0.000
H01.1 Non-infectious dermatoses of eyelid	0.003	0.997	0.000
H02.6 Xanthelasma of eyelid	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
C18.6 Descending colon	0.000	0.997	0.003
H03.8 Involvement of eyelid in other diseases classified elsewhere	0.003	0.997	0.000
H03.1 Involvement of eyelid in other infectious diseases classified elsewhere	0.003	0.997	0.000
H03.0 Parasitic infestation of eyelid in diseases classified elsewhere	0.003	0.997	0.000
M54.6 Pain in thoracic spine	0.000	0.997	0.003
T51.9 Alcohol, unspecified	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
M54.56 Low back pain (Lumbar region)	0.000	0.997	0.003
M54.8 Other dorsalgia	0.000	0.997	0.003
M54.0 Panniculitis affecting regions of neck and back	0.000	0.997	0.003
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M54.37 Sciatica (Lumbosacral region)	0.000	0.997	0.003
M54.35 Sciatica (Thoracolumbar region)	0.000	0.997	0.003
M54.34 Sciatica-Thoracic	0.000	0.997	0.003
M54.33 Sciatica-Cervicothoracic	0.000	0.997	0.003
M54.32 Sciatica-Cervical	0.000	0.997	0.003
M54.31 Sciatica-Occipit-atl-axl	0.000	0.997	0.003
M54.30 Sciatica (Multiple sites in spine)	0.000	0.997	0.003
K31.8 Other specified diseases of stomach and duodenum	0.003	0.997	0.000
H02.3 Blepharochalasis	0.003	0.997	0.000
M54.4 Lumbago with sciatica	0.000	0.997	0.003
T45.5 Anticoagulants	0.003	0.997	0.000
Z03.5 Observation for other suspected cardiovascular diseases	0.000	0.997	0.003
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.6 Other and unspecified narcotics	0.003	0.997	0.000
T40.5 Cocaine	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
O26.9 Pregnancy-related condition, unspecified	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M54.97 Dorsalgia, unspecified (Lumbosacral region)	0.000	0.997	0.003
M54.95 Dorsalgia, unspecified (Thoracolumbar region)	0.000	0.997	0.003
M54.93 Dorsalgia, unspecified (Cervicothoracic region)	0.000	0.997	0.003
M54.92 Dorsalgia, unspecified (Cervical region)	0.000	0.997	0.003
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)	0.000	0.997	0.003
M54.90 Dorsalgia, unspecified (Multiple sites in spine)	0.000	0.997	0.003
C18.3 Hepatic flexure	0.000	0.997	0.003
T18 Foreign body in alimentary tract	0.003	0.997	0.000
M54.96 Dorsalgia, unspecified (Lumbar region)	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
C18.8 Overlapping lesion of colon	0.000	0.997	0.003
C18.1 Appendix	0.000	0.997	0.003
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
K63.9 Disease of intestine, unspecified	0.000	0.997	0.003
M54.22 Cervicalgia (Cervical region)	0.000	0.997	0.003
E07.9 Disorder of thyroid, unspecified	0.003	0.997	0.000
E89.0 Postprocedural hypothyroidism	0.003	0.997	0.000
C18.0 Caecum	0.000	0.997	0.003
H02.7 Other degenerative disorders of eyelid and periocular area	0.003	0.997	0.000
H02.2 Lagophthalmos	0.003	0.997	0.000
K63.1 Perforation of intestine (nontraumatic)	0.000	0.997	0.003
Z03.1 Observation for suspected malignant neoplasm	0.000	0.997	0.003
H02.5 Other disorders affecting eyelid function	0.003	0.997	0.000
M54.1 Radiculopathy	0.000	0.997	0.003
S64.4 Injury of digital nerve of other finger	0.003	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
K63 Other diseases of intestine	0.000	0.997	0.003
T51 Toxic effect of alcohol	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
K31 Other diseases of stomach and duodenum	0.003	0.997	0.000
S61 Open wound of wrist and hand	0.003	0.997	0.000
O70.1 Second degree perineal laceration during delivery	0.000	0.997	0.003
Z03.3 Observation for suspected nervous system disorder	0.000	0.997	0.003
N35.8 Other urethral stricture	0.000	0.997	0.003
N35.1 Postinfective urethral stricture, not elsewhere classified	0.000	0.997	0.003
N35.0 Posttraumatic urethral stricture	0.000	0.997	0.003
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.003	0.997	0.000
M54.29 Cervicalgia-Site unspe	0.000	0.997	0.003
M54.28 Cervicalgia-Sacral/sacrococ	0.000	0.997	0.003
M54.27 Cervicalgia-Lumbosacral	0.000	0.997	0.003
M54.26 Cervicalgia-Lumbar	0.000	0.997	0.003
M54.25 Cervicalgia-Thoracolumbar	0.000	0.997	0.003
M54.24 Cervicalgia-Thoracic	0.000	0.997	0.003
M54.23 Cervicalgia (Cervicothoracic region)	0.000	0.997	0.003
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.000	0.997	0.003
M54.20 Cervicalgia-Mult site	0.000	0.997	0.003
Y43 Primarily systemic agents	0.003	0.997	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.003	0.997	0.000
K63.5 Polyp of colon	0.000	0.997	0.003
Z03.0 Observation for suspected tuberculosis	0.000	0.997	0.003
K31.7 Polyp of stomach and duodenum	0.003	0.997	0.000
O26.7 Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O26.6 Liver disorders in pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O26.5 Maternal hypotension syndrome	0.003	0.997	0.000
O26.4 Herpes gestationis	0.003	0.997	0.000
O26.3 Retained intra-uterine contraceptive device in pregnancy	0.003	0.997	0.000
O26.2 Pregnancy care of habitual aborter	0.003	0.997	0.000
O26.1 Low weight gain in pregnancy	0.003	0.997	0.000
O26.0 Excessive weight gain in pregnancy	0.003	0.997	0.000
T15-T19 Effects of foreign body entering through natural orifice	0.003	0.997	0.000
C18.5 Splenic flexure	0.000	0.997	0.002
T39.1 4-Aminophenol derivatives	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
N30 Cystitis	0.000	0.997	0.003
K31.5 Obstruction of duodenum	0.003	0.997	0.000
Z03.8 Observation for other suspected diseases and conditions	0.000	0.997	0.003
Z03.6 Observation for suspected toxic effect from ingested substance	0.000	0.997	0.002
E89.2 Postprocedural hypoparathyroidism	0.003	0.997	0.000
S64 Injury of nerves at wrist and hand level	0.003	0.997	0.000
M54.64 Pain in thoracic spine (Thoracic region)	0.000	0.997	0.002
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.003	0.997	0.000
M54.69 Pain in thoracic spine-Site unspe	0.000	0.997	0.002
M54.68 Pain in thoracic spine-Sacral/sacrococ	0.000	0.997	0.002
M54.67 Pain in thoracic spine-Lumbosacral	0.000	0.997	0.002
M54.66 Pain in thoracic spine-Lumbar	0.000	0.997	0.002
M54.65 Pain in thoracic spine (Thoracolumbar region)	0.000	0.997	0.002
M54.63 Pain in thoracic spine (Cervicothoracic region)	0.000	0.997	0.002
M54.62 Pain in thoracic spine-Cervical	0.000	0.997	0.002
M54.61 Pain in thoracic spine-Occipit-atl-axl	0.000	0.997	0.002
M54.60 Pain in thoracic spine (Multiple sites in spine)	0.000	0.997	0.002
S92.30 Fracture of metatarsal bone (closed)	0.002	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.997	0.000
T36.8 Other systemic antibiotics	0.002	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.997	0.000
T36.6 Rifamycins	0.002	0.997	0.000
T36.5 Aminoglycosides	0.002	0.997	0.000
T36.4 Tetracyclines	0.002	0.997	0.000
T36.3 Macrolides	0.002	0.997	0.000
T36.2 Chloramphenicol group	0.002	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.997	0.000
T36.0 Penicillins	0.002	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.997	0.000
T37.5 Antiviral drugs	0.002	0.997	0.000
T37.4 Anthelminthics	0.002	0.997	0.000
T37.3 Other antiprotozoal drugs	0.002	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
T37.1 Antimycobacterial drugs	0.002	0.997	0.000
T37.0 Sulphonamides	0.002	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.997	0.000
T38.7 Androgens and anabolic congeners	0.002	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.997	0.000
T38.5 Other oestrogens and progestogens	0.002	0.997	0.000
T38.4 Oral contraceptives	0.002	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.997	0.000
T38.2 Antithyroid drugs	0.002	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.997	0.000
T41.5 Therapeutic gases	0.002	0.997	0.000
T41.4 Anaesthetic, unspecified	0.002	0.997	0.000
T41.3 Local anaesthetics	0.002	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.997	0.000
T41.1 Intravenous anaesthetics	0.002	0.997	0.000
T41.0 Inhaled anaesthetics	0.002	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.997	0.000
T46.7 Peripheral vasodilators	0.002	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.997	0.000
T46.1 Calcium-channel blockers	0.002	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.997	0.000
T47.7 Emetics	0.002	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.997	0.000
T47.5 Digestants	0.002	0.997	0.000
T47.4 Other laxatives	0.002	0.997	0.000
T47.3 Saline and osmotic laxatives	0.002	0.997	0.000
T47.2 Stimulant laxatives	0.002	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.997	0.000
T48.5 Anti-common-cold drugs	0.002	0.997	0.000
T48.4 Expectorants	0.002	0.997	0.000
T48.3 Antitussives	0.002	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.997	0.000
T48.0 Oxytocic drugs	0.002	0.997	0.000
T49.9 Topical agent, unspecified	0.002	0.997	0.000
T49.8 Other topical agents	0.002	0.997	0.000
T49.7 Dental drugs, topically applied	0.002	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.997	0.000
T49.2 Local astringents and local detergents	0.002	0.997	0.000
T49.1 Antipruritics	0.002	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.997	0.000
E27 Other disorders of adrenal gland	0.003	0.997	0.000
M54.09 Panniculitis affecting regions of neck and back (Site unspecified)	0.000	0.997	0.002
M54.08 Panniculitis affecting regions of neck and back (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M54.07 Panniculitis affecting regions of neck and back (Lumbosacral region)	0.000	0.997	0.002
M54.06 Panniculitis affecting regions of neck and back (Lumbar region)	0.000	0.997	0.002
M54.05 Panniculitis affecting regions of neck and back (Thoracolumbar region)	0.000	0.997	0.002
M54.04 Panniculitis affecting regions of neck and back (Thoracic region)	0.000	0.997	0.002
M54.03 Panniculitis affecting regions of neck and back (Cervicothoracic region)	0.000	0.997	0.002
M54.02 Panniculitis affecting regions of neck and back (Cervical region)	0.000	0.997	0.002
M54.01 Panniculitis affecting regions of neck and back (Occipito-atlanto-axial region)	0.000	0.997	0.002
M54.00 Panniculitis affecting regions of neck and back (Multiple sites in spine)	0.000	0.997	0.002
M54.89 Other dorsalgia (Site unspecified)	0.000	0.997	0.002
M54.88 Other dorsalgia (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M54.87 Other dorsalgia (Lumbosacral region)	0.000	0.997	0.002
M54.86 Other dorsalgia (Lumbar region)	0.000	0.997	0.002
M54.85 Other dorsalgia (Thoracolumbar region)	0.000	0.997	0.002
M54.84 Other dorsalgia (Thoracic region)	0.000	0.997	0.002
M54.83 Other dorsalgia (Cervicothoracic region)	0.000	0.997	0.002
M54.82 Other dorsalgia (Cervical region)	0.000	0.997	0.002
M54.81 Other dorsalgia (Occipito-atlanto-axial region)	0.000	0.997	0.002
M54.80 Other dorsalgia (Multiple sites in spine)	0.000	0.997	0.002
M23.23 Derangement of meniscus due to old tear or injury (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.997	0.003
H02.8 Other specified disorders of eyelid	0.002	0.997	0.000
S60-S69 Injuries to the wrist and hand	0.002	0.997	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.000	0.997	0.002
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M54.47 Lumbago with sciatica (Lumbosacral region)	0.000	0.997	0.002
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.000	0.997	0.002
M54.44 Lumbago with sciatica-Thoracic	0.000	0.997	0.002
M54.43 Lumbago with sciatica-Cervicothoracic	0.000	0.997	0.002
M54.42 Lumbago with sciatica-Cervical	0.000	0.997	0.002
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.000	0.997	0.002
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.000	0.997	0.002
K31.4 Gastric diverticulum	0.002	0.997	0.000
M54.94 Dorsalgia, unspecified (Thoracic region)	0.000	0.998	0.002
K31.1 Adult hypertrophic pyloric stenosis	0.002	0.998	0.000
S92.3 Fracture of metatarsal bone	0.002	0.998	0.000
S92 Fracture of foot, except ankle	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.002	0.998	0.000
E89.3 Postprocedural hypopituitarism	0.002	0.998	0.000
K63.8 Other specified diseases of intestine	0.000	0.998	0.002
S30.2 Contusion of external genital organs	0.002	0.998	0.000
S90-S99 Injuries to the ankle and foot	0.002	0.998	0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.002	0.998	0.000
E27.2 Addisonian crisis	0.002	0.998	0.000
T79-T79 Certain early complications of trauma	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
K63.2 Fistula of intestine	0.000	0.998	0.002
E05 Thyrotoxicosis [hyperthyroidism]	0.002	0.998	0.000
O63.0 Prolonged first stage (of labour)	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
E07 Other disorders of thyroid	0.002	0.998	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.998	0.002
T18.9 Foreign body in alimentary tract, part unspecified	0.002	0.998	0.000
T18.8 Foreign body in other and multiple parts of alimentary tract	0.002	0.998	0.000
T18.5 Foreign body in anus and rectum	0.002	0.998	0.000
T18.4 Foreign body in colon	0.002	0.998	0.000
T18.3 Foreign body in small intestine	0.002	0.998	0.000
T18.2 Foreign body in stomach	0.002	0.998	0.000
T18.0 Foreign body in mouth	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.3 Barbiturates	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
T42.1 Iminostilbenes	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
Y83.8 Other surgical procedures	0.000	0.998	0.002
Z03.2 Observation for suspected mental and behavioural disorders	0.000	0.998	0.002
S30 Superficial injury of abdomen, lower back and pelvis	0.002	0.998	0.000
T79 Certain early complications of trauma, not elsewhere classified	0.002	0.998	0.000
S83.2 Tear of meniscus, current	0.002	0.998	0.000
N30.3 Trigonitis	0.000	0.998	0.002
T63 Toxic effect of contact with venomous animals	0.002	0.998	0.000
E27.1 Primary adrenocortical insufficiency	0.002	0.998	0.000
S68 Traumatic amputation of wrist and hand	0.002	0.998	0.000
M54.12 Radiculopathy (Cervical region)	0.000	0.998	0.002
H02.1 Ectropion of eyelid	0.002	0.998	0.000
T79.8 Other early complications of trauma	0.002	0.998	0.000
M54.19 Radiculopathy (Site unspecified)	0.000	0.998	0.002
M54.18 Radiculopathy (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M54.17 Radiculopathy (Lumbosacral region)	0.000	0.998	0.002
M54.15 Radiculopathy (Thoracolumbar region)	0.000	0.998	0.002
M54.14 Radiculopathy (Thoracic region)	0.000	0.998	0.002
M54.13 Radiculopathy (Cervicothoracic region)	0.000	0.998	0.002
M54.11 Radiculopathy (Occipito-atlanto-axial region)	0.000	0.998	0.002
M54.10 Radiculopathy (Multiple sites in spine)	0.000	0.998	0.002
O28.1 Abnormal biochemical finding on antenatal screening of mother	0.002	0.998	0.000
E83 Disorders of mineral metabolism	0.002	0.998	0.000
O20-O29 Other maternal disorders predominantly related to pregnancy	0.002	0.998	0.000
K63.4 Enteroptosis	0.000	0.998	0.002
K63.0 Abscess of intestine	0.000	0.998	0.002
N30.8 Other cystitis	0.000	0.998	0.002
T51.8 Other alcohols	0.002	0.998	0.000
T51.3 Fusel oil	0.002	0.998	0.000
T51.2 2-Propanol	0.002	0.998	0.000
T51.1 Methanol	0.002	0.998	0.000
Z90.1 Acquired absence of breast(s)	0.002	0.998	0.000
E46 Unspecified protein-energy malnutrition	0.002	0.998	0.000
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.002	0.998	0.000
K31.6 Fistula of stomach and duodenum	0.002	0.998	0.000
K31.3 Pylorospasm, not elsewhere classified	0.002	0.998	0.000
K31.2 Hourglass stricture and stenosis of stomach	0.002	0.998	0.000
K31.0 Acute dilatation of stomach	0.002	0.998	0.000
S61.7 Multiple open wounds of wrist and hand	0.002	0.998	0.000
S68.1 Traumatic amputation of other single finger (complete)(partial)	0.002	0.998	0.000
O28 Abnormal findings on antenatal screening of mother	0.002	0.998	0.000
K63.3 Ulcer of intestine	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
O63 Long labour	0.000	0.998	0.002
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.002	0.998	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.002	0.998	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.002	0.998	0.000
E89.5 Postprocedural testicular hypofunction	0.002	0.998	0.000
E89.4 Postprocedural ovarian failure	0.002	0.998	0.000
E89.1 Postprocedural hypoinsulinaemia	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
T65 Toxic effect of other and unspecified substances	0.002	0.998	0.000
T62 Toxic effect of other noxious substances eaten as food	0.002	0.998	0.000
T61 Toxic effect of noxious substances eaten as seafood	0.002	0.998	0.000
T60 Toxic effect of pesticides	0.002	0.998	0.000
T59 Toxic effect of other gases, fumes and vapours	0.002	0.998	0.000
T57 Toxic effect of other inorganic substances	0.002	0.998	0.000
T56 Toxic effect of metals	0.002	0.998	0.000
T54 Toxic effect of corrosive substances	0.002	0.998	0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.002	0.998	0.000
T52 Toxic effect of organic solvents	0.002	0.998	0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.002	0.998	0.000
T58 Toxic effect of carbon monoxide	0.002	0.998	0.000
T55 Toxic effect of soaps and detergents	0.002	0.998	0.000
N39.4 Other specified urinary incontinence	0.000	0.998	0.002
T19 Foreign body in genito-urinary tract	0.002	0.998	0.000
T15 Foreign body on external eye	0.002	0.998	0.000
T16 Foreign body in ear	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations